MY8100204A - Influenza vaccines - Google Patents

Influenza vaccines

Info

Publication number
MY8100204A
MY8100204A MY204/81A MY8100204A MY8100204A MY 8100204 A MY8100204 A MY 8100204A MY 204/81 A MY204/81 A MY 204/81A MY 8100204 A MY8100204 A MY 8100204A MY 8100204 A MY8100204 A MY 8100204A
Authority
MY
Malaysia
Prior art keywords
influenza vaccines
influenza
vaccines
Prior art date
Application number
MY204/81A
Other languages
English (en)
Inventor
Helmut Bachmayer
Gerhard Schmidt
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY8100204A publication Critical patent/MY8100204A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
MY204/81A 1974-01-14 1981-12-30 Influenza vaccines MY8100204A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en, 2012) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
MY8100204A true MY8100204A (en) 1981-12-31

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
MY204/81A MY8100204A (en) 1974-01-14 1981-12-30 Influenza vaccines

Country Status (27)

Country Link
JP (2) JPS58407B2 (en, 2012)
AT (1) AT345449B (en, 2012)
AU (1) AU500250B2 (en, 2012)
BE (1) BE824372A (en, 2012)
CA (1) CA1049406A (en, 2012)
CH (1) CH589453A5 (en, 2012)
CS (1) CS191254B2 (en, 2012)
DD (1) DD116239A5 (en, 2012)
DE (1) DE2500785B2 (en, 2012)
DK (1) DK140003B (en, 2012)
ES (1) ES433759A1 (en, 2012)
FI (1) FI54053C (en, 2012)
FR (1) FR2257305B1 (en, 2012)
GB (1) GB1498261A (en, 2012)
HK (1) HK56380A (en, 2012)
HU (1) HU173920B (en, 2012)
IE (1) IE40794B1 (en, 2012)
IL (1) IL46426A (en, 2012)
MY (1) MY8100204A (en, 2012)
NL (1) NL166622C (en, 2012)
NO (1) NO143128C (en, 2012)
PH (1) PH14458A (en, 2012)
PL (1) PL93689B1 (en, 2012)
SE (1) SE427238B (en, 2012)
SU (1) SU616997A3 (en, 2012)
YU (1) YU41289B (en, 2012)
ZA (1) ZA75259B (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
CA2627971A1 (en) * 2005-11-01 2007-05-10 Novartis Vaccines And Diagnostics Gmbh & Co Kg. Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment
EP2192917B1 (en) * 2007-08-28 2014-01-29 Baxter International Inc. Method for producing viral vaccines
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
GB1498261A (en) 1978-01-18
AT345449B (de) 1978-09-11
CA1049406A (en) 1979-02-27
NO750031L (en, 2012) 1975-08-11
NL166622C (nl) 1981-09-15
SU616997A3 (ru) 1978-07-25
DE2500785A1 (de) 1975-07-31
PH14458A (en) 1981-07-29
IE40794L (en) 1975-07-14
YU5875A (en) 1984-04-30
DK1475A (en, 2012) 1975-09-01
NL7500301A (nl) 1975-07-16
HU173920B (hu) 1979-09-28
CS191254B2 (en) 1979-06-29
NL166622B (nl) 1981-04-15
YU41289B (en) 1987-02-28
PL93689B1 (en, 2012) 1977-06-30
JPS56127319A (en) 1981-10-06
HK56380A (en) 1980-10-16
FR2257305A1 (en, 2012) 1975-08-08
DK140003C (en, 2012) 1979-10-29
CH589453A5 (en, 2012) 1977-07-15
JPS58407B2 (ja) 1983-01-06
DE2500785B2 (de) 1980-01-03
IL46426A0 (en) 1975-04-25
FR2257305B1 (en, 2012) 1982-03-19
FI750014A7 (en, 2012) 1975-07-15
DE2500785C3 (en, 2012) 1980-09-11
SE7500130L (en, 2012) 1975-07-15
JPS6035326B2 (ja) 1985-08-14
FI54053C (fi) 1978-10-10
JPS50100224A (en, 2012) 1975-08-08
ATA21475A (de) 1978-01-15
ZA75259B (en) 1976-08-25
DD116239A5 (en, 2012) 1975-11-12
AU500250B2 (en) 1979-05-17
BE824372A (fr) 1975-07-14
SE427238B (sv) 1983-03-21
AU7730575A (en) 1976-07-15
NO143128C (no) 1980-12-29
FI54053B (fi) 1978-06-30
NO143128B (no) 1980-09-15
IE40794B1 (en) 1979-08-15
DK140003B (da) 1979-06-05
ES433759A1 (es) 1977-02-16
IL46426A (en) 1978-01-31

Similar Documents

Publication Publication Date Title
IL47465A0 (en) Methyl 5-propylthio-2-benzimidazole-carbamate
CS621475A2 (en) Zpusob soucasneho stanoveni nekolika nebo vsech isoenzymu laktatdihydrogenazy
JPS5217201A (en) Fluiddoperated means
JPS5115704A (en) Kyukibenojushinai fukunenshoshitsukaranaru nainenkikan
GB1531718A (en) Phenylethanolamines
HK56380A (en) Influenza vaccines
AU498810B2 (en) Influenza vaccines
AU8570375A (en) Phospholipide immunostimulant
CH610780A5 (en) Autoclave
AU8657275A (en) Nds
ZA753921B (en) Aqueous rafoxanide formulations
AU7096274A (en) Vaccine
IL48695A (en) Preparation of -oxo-thiodimethylamides
AU503647B2 (en) Antipregnancy vaccine
JPS5120688A (en) Roran c jushinkyo fuirutasochi
JPS5131712A (en) Garasu no seizohoho
JPS5182910A (en) Doren mataha dorensono keiseihoho
JPS5126889A (en) Sefuarosuhorin c no saishuho
JPS5110138A (en) Denkikamisorino ha
JPS51509A (en) Garasu aruiha furitsutonoyokaiyosoyomataha saiyokaisoyo
JPS5132791A (en) Sefuarosuhorin c nosaishu seiseiho
BE827145A (fr) Vaccin
ZA757596B (en) Autoclave
GB1522011A (en) Stop means
JPS5114098A (en) Insatsubutsuno moyokenshutsusochi